Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1973 1
1976 1
1977 1
1978 1
1981 1
1986 2
1987 3
1988 1
1989 5
1990 5
1991 6
1992 2
1993 2
1994 3
1995 11
1996 4
1997 2
1998 2
1999 6
2000 4
2001 5
2002 7
2003 12
2004 11
2005 8
2006 5
2007 7
2008 10
2009 12
2010 15
2011 8
2012 27
2013 28
2014 31
2015 23
2016 30
2017 29
2018 42
2019 38
2020 39
2021 73
2022 61
2023 80
2024 43

Text availability

Article attribute

Article type

Publication date

Search Results

630 results

Results by year

Filters applied: . Clear all
Page 1
Meloxicam.
Khalil NY, Aldosari KF. Khalil NY, et al. Profiles Drug Subst Excip Relat Methodol. 2020;45:159-197. doi: 10.1016/bs.podrm.2019.10.006. Epub 2019 Dec 12. Profiles Drug Subst Excip Relat Methodol. 2020. PMID: 32164967
Losartan: Comprehensive Profile.
Al-Majed AR, Assiri E, Khalil NY, Abdel-Aziz HA. Al-Majed AR, et al. Among authors: khalil ny. Profiles Drug Subst Excip Relat Methodol. 2015;40:159-94. doi: 10.1016/bs.podrm.2015.02.003. Epub 2015 Apr 9. Profiles Drug Subst Excip Relat Methodol. 2015. PMID: 26051686 Review.
Isotretinoin.
Khalil NY, Darwish IA, Al-Qahtani AA. Khalil NY, et al. Profiles Drug Subst Excip Relat Methodol. 2020;45:119-157. doi: 10.1016/bs.podrm.2019.10.005. Epub 2019 Dec 6. Profiles Drug Subst Excip Relat Methodol. 2020. PMID: 32164966
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry.
Hambly N, Farooqi MM, Dvorkin-Gheva A, Donohoe K, Garlick K, Scallan C, Chong SG, MacIsaac S, Assayag D, Johannson KA, Fell CD, Marcoux V, Manganas H, Morisset J, Comes A, Fisher JH, Shapera S, Gershon AS, To T, Wong AW, Sadatsafavi M, Wilcox PG, Halayko AJ, Khalil N, Cox G, Richeldi L, Ryerson CJ, Kolb M. Hambly N, et al. Among authors: khalil n. Eur Respir J. 2022 Oct 6;60(4):2102571. doi: 10.1183/13993003.02571-2021. Print 2022 Oct. Eur Respir J. 2022. PMID: 35273032 Free article.
Clenbuterol Hydrochloride.
Al-Majed AA, Khalil NY, Khbrani I, Abdel-Aziz HA. Al-Majed AA, et al. Among authors: khalil ny. Profiles Drug Subst Excip Relat Methodol. 2017;42:91-123. doi: 10.1016/bs.podrm.2017.02.002. Epub 2017 Mar 31. Profiles Drug Subst Excip Relat Methodol. 2017. PMID: 28431781
Association of Particulate Matter Exposure With Lung Function and Mortality Among Patients With Fibrotic Interstitial Lung Disease.
Goobie GC, Carlsten C, Johannson KA, Khalil N, Marcoux V, Assayag D, Manganas H, Fisher JH, Kolb MRJ, Lindell KO, Fabisiak JP, Chen X, Gibson KF, Zhang Y, Kass DJ, Ryerson CJ, Nouraie SM. Goobie GC, et al. Among authors: khalil n. JAMA Intern Med. 2022 Dec 1;182(12):1248-1259. doi: 10.1001/jamainternmed.2022.4696. JAMA Intern Med. 2022. PMID: 36251286 Free PMC article.
Association of Endovascular Thrombectomy vs Medical Management With Functional and Safety Outcomes in Patients Treated Beyond 24 Hours of Last Known Well: The SELECT Late Study.
Sarraj A, Kleinig TJ, Hassan AE, Portela PC, Ortega-Gutierrez S, Abraham MG, Manning NW, Siegler JE, Goyal N, Maali L, Blackburn S, Wu TY, Blasco J, Renú A, Sangha NS, Arenillas JF, McCullough-Hicks ME, Wallace A, Gibson D, Pujara DK, Shaker F, de Lera Alfonso M, Olivé-Gadea M, Farooqui M, Vivanco Suarez JS, Iezzi Z, Khalife J, Lechtenberg CG, Qadri SK, Moussa RB, Abdulrazzak MA, Almaghrabi TS, Mir O, Beharry J, Krishnaiah B, Miller M, Khalil N, Sharma GJ, Katsanos AH, Fadhil A, Duncan KR, Hu Y, Martin-Schild SB, Tsivgoulis GK, Cordato D, Furlan A, Churilov L, Mitchell PJ, Arthur AS, Parsons MW, Grotta JC, Sitton CW, Ribo M, Albers GW, Campbell BCV. Sarraj A, et al. Among authors: khalil n. JAMA Neurol. 2023 Feb 1;80(2):172-182. doi: 10.1001/jamaneurol.2022.4714. JAMA Neurol. 2023. PMID: 36574257 Free PMC article.
Thiouracil: Comprehensive profile.
Khalil NY, AlRabiah HK, Almousa MS, Bari A, Alkahtani HM. Khalil NY, et al. Profiles Drug Subst Excip Relat Methodol. 2019;44:293-331. doi: 10.1016/bs.podrm.2018.11.006. Epub 2019 Jan 10. Profiles Drug Subst Excip Relat Methodol. 2019. PMID: 31029221
Topiramate: Comprehensive profile.
Khalil NY, AlRabiah HK, Al Rashoud SS, Bari A, Wani TA. Khalil NY, et al. Profiles Drug Subst Excip Relat Methodol. 2019;44:333-378. doi: 10.1016/bs.podrm.2018.11.005. Epub 2019 Jan 14. Profiles Drug Subst Excip Relat Methodol. 2019. PMID: 31029222
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency.
Raghu G, Ghazipura M, Fleming TR, Aronson KI, Behr J, Brown KK, Flaherty KR, Kazerooni EA, Maher TM, Richeldi L, Lasky JA, Swigris JJ, Busch R, Garrard L, Ahn DH, Li J, Puthawala K, Rodal G, Seymour S, Weir N, Danoff SK, Ettinger N, Goldin J, Glassberg MK, Kawano-Dourado L, Khalil N, Lancaster L, Lynch DA, Mageto Y, Noth I, Shore JE, Wijsenbeek M, Brown R, Grogan D, Ivey D, Golinska P, Karimi-Shah B, Martinez FJ. Raghu G, et al. Among authors: khalil n. Am J Respir Crit Care Med. 2024 Mar 15;209(6):647-669. doi: 10.1164/rccm.202312-2213SO. Am J Respir Crit Care Med. 2024. PMID: 38174955
630 results